The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia


      The effects of dietary isoflavone supplementation using a purified extract of red clover containing approximately biochanin A 26 mg, formononetin 16 mg, daidzein 0.5 mg and genistein 1 mg per tablet at doses of one or two tablets per day were compared to placebo in a three-period, randomised, double blind, ascending dose study in 66 post menopausal women with plasma cholesterol levels between 5.0 and 9.0 mmol/l. Each treatment period lasted 4 weeks and a further nine women received placebo for the full 12-week period. All women consumed a low isoflavone diet for 2 weeks preceding the commencement of the study and for the 12-week study period. Urinary isoflavone excretion was very low in subjects receiving placebo but increased in a dose-dependent manner during therapy with one and two of isoflavone tablets. Dietary supplementation with isoflavones did not significantly alter total plasma cholesterol, LDL cholesterol, HDL cholesterol or plasma triglyceride levels. However, inverse correlations were found between urinary genistein excretion and plasma triglyceride levels and between urinary O-DMA excretion (an isoflavone metabolite) and plasma triglyceride levels in subjects receiving one isoflavone tablet, suggesting a weak relationship between isoflavone intake and plasma triglycerides which may be influenced by individual differences in isoflavone absorption or metabolism. The results suggest that isoflavone phytoestrogens from red clover in the proportions and quantities studied do not significantly alter plasma lipids in post menopausal women with moderately elevated plasma cholesterol levels.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Nagata C.
        • Takatsua N.
        • Kurisu Y.
        • Shimizu H.
        Decreased serum total cholesterol concentration is associated with high intake of soy products in Japanese men and women.
        J. Nutr. 1997; 12: 209-213
        • Anderson J.W.
        • Johnstone B.M.
        • Cook-Newell M.E.
        Meta-analysis of the effects of soy protein intake on serum lipids.
        N. Engl. J. Med. 1995; 333: 275-282
        • Anthony M.S.
        • Clarkson T.B.
        • Bullock B.C.
        • Wagner J.D.
        Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male Cynomolgus monkeys.
        Arterioscler. Thromb. Vasc. Biol. 1997; 17: 224-231
        • Anthony M.S.
        • Clarkson T.B.
        • Hughes Jr, C.L.
        • Morgan T.M.
        • Burke G.L.
        Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal Rhesus monkeys.
        J. Nutr. 1996; 126: 43-50
        • Grundy S.M.
        • Abrams J.J.
        Comparison of actions of soy protein and casein on metabolism of plasma lipoproteins and cholesterol in humans.
        Am. J. Clin. Nutr. 1983; 30: 245-252
        • Sacks F.M.
        • Castelli W.P.
        • Donner A.
        • Kass E.H.
        Plasma lipids and lipoproteins in vegetarians and controls.
        N. Engl. J. Med. 1975; 292: 1148-1151
        • Sirtori C.R.
        • Lovat M.R.
        • Manzoni C.
        • Monetti M.
        • Pazzucconi F.
        • Gatti E.
        Soy and cholesterol reduction: clinical experience.
        J. Nutr. 1995; 25: 598S-605S
      1. Howes JB, Waring M, Huang L, Howes LG. Acute and chronic pharmacokinetics of an extract of isoflavones from red clover. Clin Pharmacokinet;1999, submitted.

        • Aldercreutz H.
        • Honjo H.
        • Higashi A.
        • Fotsis T.
        • Hamalainen E.
        • Hasegawa T.
        • Okada H.
        Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet.
        Am. J. Clin. Nutr. 1991; 54: 1093-1100
        • Hodgson J.M.
        • Puddey I.B.
        • Beilin L.J.
        • Mori T.A.
        • Croft K.D.
        Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomised controlled trial in humans.
        J. Nutr. 1998; 128: 728-732
        • Baum J.A.
        • Teng H.
        • Erdman J.W.
        • Weigel R.M.
        • Klein B.P.
        • Persky V.W.
        • Freels S.
        • Surya P.
        • Bakhit R.M.
        • Ramos E.
        • Shay N.F.
        • Potter S.M.
        Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low density lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women.
        Am. J. Clin. Nutr. 1998; 68: 545-551